Johnson & Johnson Files Form 144 Notice for Potential Stock Sale

Johnson & Johnson (JNJ) has submitted a Form 144 notice to the Securities and Exchange Commission (SEC), detailing its plan to sell common stock through J.P. Morgan Securities LLC on the New York Stock Exchange (NYSE).

The notice, filed on August 5, 2026, lists two executive compensation transactions: 4,625 shares of common stock dated February 15, 2026, and 43,855 shares dated February 13, 2026.

Form 144 is a regulatory document that requires investors to disclose their plans to sell a large number of shares. This helps maintain transparency in the market and ensures that all parties are aware of the potential impact on the stock's price.